1 The wide distribution of the uridine nucleotide-activated P2Y 2 , P2Y 4 and P2Y 6 receptors suggests a role for UTP as an important extracellular signalling molecule. However, direct evidence for UTP release and extracellular accumulation has been addressed only recently due to the lack of a sensitive assay for UTP mass. In the present study, we describe a method that is based on the uridinylation of [ ]-UDP-glucose was linearly observed between 1 and 300 nM UTP. The reaction was highly speci®c for UTP and was unaected by a 1000 fold molar excess of ATP over UTP. 3 Release of UTP was measured with a variety of cells including platelets and leukocytes, primary airway epithelial cells, rat astrocytes and several cell lines. In most resting attached cultures, extracellular UTP concentrations were found in the low nanomolar range (1 ± 10 nM in 0.5 ml medium bathing 2.5 cm 2 dish). Up to a 20 fold increase in extracellular UTP levels was observed in cells subjected to a medium change. Extracellular UTP levels were 10 ± 30% of the ATP levels in both resting and mechanically-stimulated cultured cells. In unstirred platelets, a 1 : 100 ratio UTP/ ATP was observed. Extracellular UTP and ATP increased 10 fold in thrombin-stimulated platelets. 4 Detection of UTP in nanomolar concentrations in the medium bathing resting cultures suggests that constitutive release of UTP may provide a mechanism of regulation of the basal activity of uridine nucleotide sensitive receptors.
Introduction
The physiological signi®cance of ATP and ADP as extracellular signalling molecules is well established (Burnstock, 1972; Gordon, 1986; Dubyak & El-Moatassim, 1993) . Both molecules are released in a regulated manner from excitatory and non-excitatory cells, and these released nucleotides interact with both the P2X receptor subfamily of ligand-gated ion channel receptors and the P2Y receptor subfamily of G protein-coupled receptors (Burnstock & Kennedy, 1985; Abbracchio et al., 1996; Fredholm et al., 1997) .
The physiological role of extracellular uridine nucleotides is less well understood. However, extracellular UTP and UDP promote widespread and pronounced cellular responses, and three of the ®ve cloned human P2Y receptors are potently activated by uridine nucleotides. The P2Y 2 receptor is activated equipotently by UTP and ATP (Lustig et al., 1993; Parr et al., 1994) , the P2Y 4 receptor is speci®cally activated by UTP (Cohen et al., 1990; Nguyen et al., 1995; Nicholas et al., 1996) , and the P2Y 6 receptor is speci®cally activated by UDP (Chang et al., 1995; Nicholas et al., 1996) . Support for the physiological importance of extracellular uridine nucleotides would be provided by direct demonstration of the regulated release of UTP from a range of tissues. However, measurement of intracellular as well as extracellular UTP levels has been dicult due to the lack of a sensitive assay for the quanti®cation of UTP mass at physiological or pharmacological levels (Anderson & Parkinson, 1997) . Recently, we have developed an enzymatic approach for quanti®cation of UTP based on the high selectivity of UDP-glucose pyrophosphorylase for UTP as a co-substrate for the conversion of glucose-1P to UDP-glucose (Lazarowski et al., 1997a) . By utilizing [ 14 C]-glucose-1P as a tracer substrate, the UTP-dependent formation of [ 14 C]-UDP-glucose was quanti®ed by HPLC and utilized to establish the occurrence of UTP release from 1321N1 human astrocytoma cells following mechanical stimulation (Lazarowski et al., 1997a) . In the present study, we describe in detail the methodology that allows accurate quanti®cation of UTP in the subnanomolar concentration range, and we establish conditions that illustrate the potential of measuring UTP at sub-picomolar levels. In addition, the intracellular and extracellular concentrations of UTP have been determined with a variety of cells, and our results suggest that both constitutive and regulated release of UTP may occur from many dierent cell types.
Methods

Cell culture
1321N1 Human astrocytoma cells and C6 rat glioma cells were grown on 24-well plastic plates (Costar) in the presence of high glucose Dulbecco's Modi®ed Eagles Medium (DMEM-H) supplemented with 5% foetal bovine serum (FBS) and antibiotics as described previously (Lazarowski & Harden, 1994; Lazarowski et al., 1997a) . Human bronchial epithelial (16HBE14o 7 ) cells were grown on vitrogen coated plates as non-polarized epithelium in the presence of DMEM-H plus 10% FBS. Cystic ®brosis (CF) tracheal epithelial (CF/T43) cells were grown on 24-well plastic plates in keratinocyte growth medium (Brown et al., 1991) . Primary human nasal epithelial cells (HNE) and T-84 human colonic epithelial cells were grown as a polarized epithelium on 12-mm transwells (costar) as described previously (Watt et al., 1998) . PC12 rat pheochromocytoma cells were grown on collagen coated 24-well plastic plates in 85% DMEM-H, 10% FBS and 5% heat inactivated horse serum. During the last 5 ± 7 days of culture, PC12 cells were dierentiated with 100 ng ml 71 nerve growth factor (Upstate Biotechnology, NY, U.S.A.) in 94% DMEM-H, 1% inactivated horse serum and 5% FBS. Con¯uent cultures of primary rat astrocytes and nerve cells grown on 12-well plastic plates were generously provided by Dr Ken McCarthy. For the experimental designs, the cells were washed (i.e., the culture medium was aspirated and the dishes immediately rinsed gently twice with 0.5 ml of pre-warmed phenol red-free DMEM-H medium) and incubated in 0.5 ml of fresh DMEM-H medium. Medium samples were collected either immediately after the cell wash (medium change) or after a 4 h incubation period under undisturbed conditions (steady state). The collected medium was rapidly centrifuged (4006g, 2 min) to remove potentially detached cells and the resulting supernatant was boiled for 1 min. Aliquots of 400 and 50 ml were used for UTP and ATP measurements, respectively. For experiments with polarized HNE and T-84 cells, only the mucosal medium was processed.
Isolation of human platelets and neutrophils
Platelets were isolated from blood of healthy donors who had not taken medication for at least 2 weeks. Blood (60 ml) containing 3.8% trisodium citrate was centrifuged at 2006g for 20 min. The platelet-rich plasma was then centrifuged for 15 min at 8006g. Contaminant red blood cells were depleted by rapid centrifugation in a microcentrifuge (2610 s at 15,000 r.p.m.). Platelets were washed twice with 10 ml DMEM-H and resuspended in phenol red-free DMEM-H at a concentration of 1.25610 8 cells ml 71 . Polymorphonuclear neutrophils (PMNs) were isolated from blood of healthy volunteers and kindly provided for this study by Dr Margrith Verghese (Verghese et al., 1996) . PMNs were suspended in phenol red-free DMEM-H at a ®nal concentration of 10 7 cells ml 71 .
Quanti®cation of UTP mass
UTP concentrations were determined using a UDP-glucose pyrophosphorylase-catalyzed reaction. Except where indicated otherwise, incubations were for 60 min in 0.5 ml phenol redfree DMEM/HEPES (pH 8.0) containing 0.5 units ml 
HPLC analysis
Glucose-1P, UDP-glucose, and UTP were separated by HPLC (Shimadzu) via a 60-A Ê Dynamax C18 column (Varian, CA, U.S.A.) with the mobile phases consisting of KH 2 PO 4 17 mM, tetrabutylethylhydrogen sulphate (TBEHS), pH 5.3 8 mM (Buer A), and 10% methanol in KH 2 PO 4 100 mM, TBEHS, pH 5.3 8 mM (Buer B). The system developed isocratically in 100% buer A for 10 min and was subsequently shifted to 100% buer B for an additional 15 min. Absorbance at 264 nm was monitored with a SPD-10A UV detector (Shimadzu), and radioactivity was determined on-line with a Flo-One Radiomatic beta detector (Packard, Canberra, Australia) as described previously (Lazarowski et al., 1997a) .
Measurement of ATP by the luciferin-luciferase assay Samples (50 ml aliquots) were diluted 1 : 6 with water. A 46luciferin-luciferase cocktail (300 mM luciferin, 5 mg ml 71 luciferase, HEPES (pH 7.8) 25 mM, MgCl 2 6.25 mM, EDTA 0.63 mM, 75 mM dithiotritiol, 1 mg ml 71 bovine serum albumin) was added to the diluted samples via a LB953 AutoLumat luminometer (Berthold GmbH, Germany). Sample luminescence was compared to an ATP standard curve performed for each individual experiment as previously described (Watt et al., 1998) .
Reagents
All nucleoside triphosphates were purchased from Pharmacia (Uppsala, Sweden). UDP-glucose pyrophosphorylase was from Boehringer Mannheim (Indianapolis, IN, U.S.A.). Luciferin, luciferase, inorganic pyrophosphatase, UDPglucose, glucose-1P, and TBEHS were from Sigma (St. Louis, MO, U.S.A.). 
Results
Lack of availability of reliable methodology for measuring UTP concentrations at low levels in biological tissues prompted us to develop a coupled enzymatic method for quantitation of UTP mass. This assay is based on the selectivity for UTP of the enzyme UDP-glucose pyrophosphorylase which converts UTP and glucose-1P into UDPglucose in the obligatory step that precedes the incorporation of glucose into glycogen (Leloir, 1971) : UTP+glucose-1P.UDP-glucose+PP i .
Although the equilibrium constant of the reaction is 0.29 ± 0.34 in the forward direction (Hansen et al., 1996) , it can be forced quantitatively in the direction of UDP-glucose synthesis by including inorganic pyrophosphatase as an enzymatic scavenger of pyrophosphate: UTP+glucose-1P.UDPglucose+PP i ?UDP-glucose+2P i .
The ®delity of the two enzymatic steps was ®rst established using [
3 H]-UTP as a substrate.
[ 3 H]-UTP (100 nM) was recovered unchanged following a 1 h incubation with UDPglucose pyrophosphorylase and inorganic pyrophosphatase in the absence of glucose-1P ( Figure 1a ). In contrast, approximately 50% of [ Figure 2a ). These results are consistent with the reported substrate speci®city of UDP-glucose pyrophosphorylase which does not utilize ATP as a substrate (Hansen et al., 1996) .
The time course of the UDP-glucose pyrophosphorylasecatalyzed reaction was determined in the presence of 1 mM glucose-1P and 100 nM UTP. Approximately 5% of the [ 14 C]-UDP-glucose was linearly dependent on the concentration of UDP-glucose pyrophosphorylase ( Figure 3b ) over a range from 5 ± 50 mg enzyme ml 71 (0.1 ± 1 units ml
71
). The reaction exhibited a pH optimum of pH 8.0 (Figure 3c ).
Since our goal was to optimize conditions to quantify UTP at physiological levels, we further examined the eciency of the conversion of UTP to UDP-glucose utilizing nanomolar and subnanomolar concentrations of UTP. In the presence of 1 mM glucose-1P, over 80% conversion of [a 33 P]-UTP to [ 33 P]-UDP-glucose occurred at all concentrations (0.1 ± 100 nM) of UTP (Figure 4a) . Thus, UTP could be quantitated at concentrations that are several orders of magnitude below its Km for the UDP-glucose pyrophosphorylase-catalyzed reaction (Km UTP=563 mM, Km glucose-1P=172 mM, Duggleby et al., 1996) . The rate of the reaction was dramatically accelerated with 1 mM glucose-1P (100% conversion in 1 min; Figure 4b ). However, the sensitivity of the assay ultimately is limited by the poor eciency of conversion observed at concentrations less than 1 mM glucose-1P (Figure 4b ). The relatively low speci®c activity of commercially available radioactive glucose-1P ([ 14 C]-UDP-glucose, SA *300 mCi mmol 71 ) also limits the total amount of radioactive substrate to 50.3 mCi ml
. (Figure 5a, left) .
One approach that would increase the sensitivity of this assay for UTP would include the use of glucose-1P with higher speci®c radioactivity, e.g., (Figure 5b, left) . Thus, the UDP-glucose pyrophosphorylase catalyzed-reaction as described here exhibits a linear dependence on UTP concentration of near ®ve orders of magnitude (20 pM UTP to 0.3 mM UTP).
In recent studies with a human astrocytoma cell line, we have observed release of UTP in pharmacologically important concentrations from mechanically-stimulated cells (Lazarowski et al., 1997a) . As a ®rst step in determining whether UTP release re¯ects a more general phenomenon, we have measured the UTP content and extracellular levels of UTP in other tissues. The concentration of UTP in each sample was compared with ATP concentration measured by the luciferinluciferase assay (Table 1) .
The intracellular amount of UTP ranged between 500 and 8000 pmol per million cells in the dierent cells studied. The cellular concentration of UTP was 10 ± 30% of that determined for ATP. Extracellular UTP was present in detectable amounts for many cells under resting conditions, but extracellular UTP was not detected (i.e., 51 nM) with non-stimulated C6 glioma cells, T84 cells, primary nerve cells and astrocytes. However, enhanced accumulation of extracellular UTP was observed after mechanical stimulation of the cells by a change of medium. As we previously observed with 1321N1 human astrocytoma cells, the ratio of extracellular UTP to ATP typically was in the range of 1 : 3 to 1 : 10 for most cells studied. The extracellular concentration of UTP was the highest with neutrophils and platelets in suspension (Table  1) probably re¯ecting cell stress and activation or damage during isolation procedures. Notably, stimulation of platelets with thrombin (2 units ml 71 ) caused a 10 fold increase in accumulation of extracellular UTP and ATP. Unlike most cells, where extracellular nucleotide ratios re¯ected the cellular content, a ratio *1 : 100 of extracellular UTP to ATP was observed with platelets while the total intracellular UTP : ATP ratio was 1 : 25 (Table 1) .
Discussion
The assay for UTP described here provides reliable detection of UTP for the ®rst time in biological samples such as cell supernatants and cell lysates. The sensitivity of this coupled enzymatic assay using [ 14 C]-glucose as a radiolabelled cosubstrate is at least two orders of magnitude greater than other methods previously available (Keppler et al., 1970 ; SasvariSzekely et al., 1975) . Moreover, we show here using radiolabelled UTP in proof of principle experiments that the assay is linear to at least the low picomolar range of concentrations of UTP. Therefore, use of [ 33 P]-glucose-1P or [ 32 P]-glucose-1P as a substrate will provide an assay of UTP mass to concentrations much lower than our results indicate exist under resting levels in the extracellular medium of a variety of cell preparations. As predicted from the previously established selectivity of UDP-glucose pyrophosphorylase for UTP, concentrations of ATP and other nucleoside triphosphates that exceeded the concentration of UTP by three orders of magnitude do not interfere with the quantitation of UTP using this assay. Further, no evidence of other interfering molecules in tissues could be ascertained from experiments in which UTP was added as an internal standard to extracts from various cell culture supernatants (data not shown). Thus, we describe a very sensitive and speci®c assay that should ®nd usefulness in accurate quantitation of UTP mass under a variety of experimental conditions.
The luciferin/luciferase assay for ATP has provided widely used methodology for quantitation of ATP mass in biological tissues at sub-nanomolar concentrations. Thus, ATP has been known for decades to exist extracellularly and to function both as an extracellular signalling molecule as well as a source for extracellular produced adenosine, which in turn activates a group of G protein-coupled adenosine receptors (Burnstock & Kennedy, 1985; Gordon, 1986) . In contrast, no information on extracellular UTP has been available until recently. Saiag et al. (1995) reported that bovine endothelial cells incorporated [ 3 H]-uridine into UTP, which then was shown to be released by mechanical stimulation of the cells. We recently reported the ®rst direct quantitation of UTP mass in extracellular medium 33 P]-UDPglucose. All incubations were for 1 h in the presence of 1 mM glucose 1-P and 0.5 units ml 71 of UDP-glucose pyrophosphorylase and inorganic pyrophosphatase. The data represent the mean value from one experiment performed with duplicate samples that diered by less than 10% from each other. The experiments were repeated at least three times and similar results were obtained. Top: ATP and UTP concentrations were determined in the medium (0.5 ml) bathing con¯uent cultures of undisturbed cells (steady state) or cells that were subjected to a medium change. Bottom: PMNs were suspended at a concentration of 10 7 ml 71 and incubated for 5 min at 378C without stirring. Platelets (1.25610 8 ml
71
) were incubated unstirred for 2 min in the absence or presence of 2 U ml 71 thrombin. Extracellular ATP and UTP concentrations (nM) are expressed as the mean value+s.e.mean and as the per cent of the total ATP and UTP cell content, respectively. The intracellular nucleotide concentrations are expressed as picomoles per million cells. *Not determined. and further illustrated that mechanical stimulation of 1321N1 human astrocytoma cells resulted in co-release of UTP with ATP (Lazarowski et al., 1997a) .
The assay of mass has been extended here to show that extracellular UTP can be detected in the medium from other neural as well as non-neural cells including normal and cystic ®brosis airway epithelial cell preparations, and from circulating leukocytes and platelets. These observations are important for a number of reasons. For example, the principle Ca 2+ -mobilizing receptor on the apical surface of human airway epithelial cells is a UTP-activated P2Y 2 receptor (Mason et al., 1991; Lazarowski et al., 1997c) . Indeed, this receptor has become an important therapeutic target for treatment of cystic ®brosis and potentially other obstructive airway disease (Knowles et al., 1991) . The availability of an assay for UTP and the observation of UTP accumulation in the extracellular medium of airway epithelial cells will provide impetus for experiments addressing the potential role that extracellular UTP may play in the physiological regulation of the airway receptor. Likewise, receptors for ATP and UTP, e.g. the P2Y 1 and P2Y 2 receptors, are dierentially expressed developmentally in various blood cell lineages (Cliord et al., 1997) . The role of UTP as an extracellular signalling molecule in in¯ammatory and immunological responses is an important topic for future investigation. Release of UTP from human platelets has not been reported previously, although UTP is thought to be co-stored with ATP in the platelet secretory granules (Goetz et al., 1971) . Our data indicates that thrombin promotes a 10 fold increase in extracellular UTP levels. However, the physiological signi®cance of this release remains to be determined since extracellular concentrations of UTP are much lower than that of ATP.
The enzyme, UDP-glucose pyrophosphorylase, which was used for quantitation of UTP levels in this study, also potentially can be utilized in studies assessing the nucleotide selectivity of the P2Y receptors. For example, we and others originally reported that the human P2Y 4 receptor is activated by high concentrations of ATP (Communi et al., 1995; Nicholas et al., 1996) , although no eect of ATP on this receptor was observed by Nguyen et al. (1995) . Subsequent studies in which the release and accumulation of UTP and UDP were minimized indicated that ATP is not an agonist at the human P2Y 4 receptor (Lazarowski et al., 1997a) , suggesting that the reported eect of ATP was likely due to its competitive action on ecto-nucleotidases acting on endogenous UTP or due to transfer of the terminal phosphate from ATP to endogenous UDP via nucleoside diphosphokinase (Lazarowski et al, 1997b) . UDP-glucose pyrophosphorylase should prove useful in addressing contributions of UTP to biological responses since ATP is not a substrate for UDP-glucose pyrophosphorylase and this enzyme eciently and rapidly metabolizes UTP when glucose-IP is present in millimolar amounts (Figure 4) . That is, UDP-glucose pyrophosphorylase provides a means for the assessment of the eect of ATP as well as other nucleotides without any confounding in¯uence of endogenous or contaminant UTP. Similarly, UDP-glucose pyrophosphorylase will be useful to assess the true potencies of nonuridine nucleotides at a pair of recently cloned nonmammalian P2Y receptors that share relatively high homology with the human P2Y 4 receptor and appear to be activated by all nucleoside triphosphates (Bogdanov et al., 1997; Boyer et al., 1997) .
The mechanism whereby non-excitatory cells release ATP (and now UTP) remains unclear. A proposed role for the cystic ®brosis transmembrane regulator CFTR in the release of nucleotides (Watt et al., 1998) was not substantiated by a number of studies including experiments with cells from the CFTR mouse as well as in experiments in which CFTR was expressed to high levels and ATP mass directly quantitated in the medium or indirectly measured at the level of the cell surface by assessing activation of co-expressed P2Y receptors (Watt et al., 1998) . The results described here comparing the concentration of UTP in the extracellular medium of a variety of non-secretory cells address neither the mechanism whereby the extracellular nucleotide appeared nor its intracellular source. Nonetheless, the similar (but not always identical) ratio of UTP to ATP in the medium relative to the cell content suggests the occurrence of a common mechanism and further suggests that these nucleotides are released by a transport mechanism that simply re¯ects the relative intracellular concentrations. It will be important to establish whether other nucleotides, e.g. CTP, GTP, are released in amounts that re¯ect their relative intracellular levels. This question takes on added signi®cance in face of the observation that in contrast to the UTP speci®city of the human P2Y 4 receptor, the rat P2Y 4 receptor is activated by both UTP and ATP as well as by ITP (Bogdanov et al., 1998) . As discussed above, an avian and a xenopus P2Y receptor have been cloned that are potently activated by all nucleoside triphosphates that have been tested.
Diculties in sampling the liquid layer immediately surrounding the cell surface limit our understanding of the potential autocrine roles of UTP and ATP. Basal levels of UTP measured in the bulk medium of`non-stimulated' cultured cells are below threshold values to promote P2Y 2 , P2Y 4 or P2Y 6 receptor stimulation (Nicholas et al., 1996) . However, as suggested from recent studies, measurements of nucleotide levels in bulk medium samples may underestimate local accumulation, e.g., at cell surface receptors. Utilizing a fusion system to anchor the ATP-speci®c enzyme luciferase to the outer cell surface of human platelets, Dubyak and colleagues observed that accumulation of ATP in the bulk medium from thrombin-stimulated platelets underestimates by at least one order of magnitude the ATP concentration in the environment near the cell surface (Beigi et al., 1999) . Experiments with mechanically stimulated hP2Y4-1321N1 cells also suggested that local accumulation of UTP was several fold higher than levels measured in the bulk medium (Lazarowski et al., 1997a) . Similarly, baseline accumulation of inositol phosphates in resting hP2Y4-1321N1 cells decreased signi®cantly after the addition of the non-speci®c nucleotidase apyrase (Lazarowski et al., 1997a) . Since ATP is not an agonist at the human P2Y 4 receptor, the most likely explanation for these results is that under resting conditions, UTP accumulates locally on the surface of 1321N1 cells in amounts sucient to activate phospholipase C through the P2Y 4 receptor. Consistent with this notion, the baseline [Ca 2+ ] signal of non-stimulated hP2Y4-1321N1 cells was markedly reduced upon inclusion of UDP-glucose pyrophosphorylase and glucose-1P in the bathing solution. (Homolya, L. & Lazarowski, E.R., unpublished) .`Constitutive' release of UTP may provide a mechanism whereby the P2Y 4 receptor, and by analogy the P2Y 2 and the P2Y 6 receptors, regulatè baseline functions' of resting cells.
In summary, the biological signi®cance of extracellular UTP has been supported in recent years by pharmacological studies of a series of G protein-coupled receptors that are potently activated by UTP or UDP. The availability of an assay capable of detecting UTP at low levels under a variety of conditions should provide important methodology for linking the release of cellular UTP to physiological responses through these receptors in a variety of tissues.
